New i-On Skincare Creams Provide Clinically-Proven De-Ironizing Inducer Technology
DII technology is designed to remove excess iron from the skin and prevent free radicals from forming—which can cause the skin to age.
DII technology is designed to remove excess iron from the skin and prevent free radicals from forming—which can cause the skin to age.
Patients treated with a topical JAK inhibitor experienced significant reductions in itch as early as day 7 and greater treatment success by week 12.
The investment will help scale the company’s 2910 nm fiber laser platforms, designed for use across all skin types.
Phase 2a trial data presented at AAD 2025 show bempikibart leads to sustained hair regrowth in severe alopecia areata, demonstrating for the first time an IL-7Rα antagonist approach.
Read MoreOne newly approved HA filler showed statistical superiority to Restylane-L at all measured time points over 12 months, while the other was superior at six and nine months despite 20% more Restylane-L being used.
Read MoreSirnaomics’ STP705 is a drug candidate for fat reduction in adults undergoing abdominoplasty. The STP705 Phase I trial results show signs of efficacy and safety.
Read MoreA peer reviewed journal article highlighting the efficacy and safety of prabotulinumtoxinA (Jeuveau) for the treatment of moderate to severe glabellar lines, also known as frown lines between the eyes, in adult patients with Skin of Color (SOC), was published recently in Dermatologic Surgery, Evolus Inc announces in a media release.
Read MoreXtalks hosts Developing a Digital Protocol for Dermatology Trials: A Step-by-Step Guide to Optimizing Research for Patients and Clinicians, Friday December 4, 2020, at 10 am EST.
Read MoreBased on encouraging safety and long-term efficacy results of the Dysport study, and continued patient satisfaction, the company is evaluating future clinical studies.
Read MoreSoftWave Tissue Regeneration Technologies announces its plan to embark on a 60-patient study for the treatment of cellulite.
Read MoreA free webinar hosted by Xtalks participants will feature a discussion about Hybrid/Virtual trials in the clinical research space and technological advances in mobile health platforms in dermatology clinical trials.
Read MorePulse Biosciences Inc announces that three clinical studies demonstrating positive results across its dermatologic portfolio are available via webcast at the virtual annual conference of the American Society for Laser Medicine and Surgery (ASLMS).
Read MoreIntegra LifeSciences Holding Corporation announces positive clinical and economic data on Integra Bilayer Wound Matrix (IBWM) in complex lower extremity reconstruction, OrthoSpineNews reports.
Read More